Patent Application
20250154539
The present invention relates to the technical field of microbial engineering, specifically to a recombinant microorganism for producing threonine and use thereof.
L-Threonine (chemically known as β-hydroxy-α-aminobutyric acid) has a molecular formula of C4H9NO3, a relative molecular mass of 119.12, and is an essential amino acid, mainly used in medicine, chemical reagents, food fortifiers, feed additives, etc.
In Corynebacterium glutamicum, the production of threonine from oxaloacetate requires a five-step catalytic reaction, the catalytic enzymes of which are aspartate kinase (encoded by lysC), aspartate semialdehyde dehydrogenase (encoded by asd), homoserine dehydrogenase (encoded by hom), homoserine kinase (encoded by thrB) and threonine synthase (encoded by thrC), respectively. Current reports on using Corynebacterium glutamicum to produce threonine mainly focus on the modification of the anabolic pathway of threonine, including: obtaining feedback-resistant homoserine dehydrogenase and aspartate kinase (Reinscheid D J, Eikmanns B J, Sahm H. Analysis of a Corynebacterium glutamicum hom gene coding for a feedback-resistant homoserine dehydrogenase.[J]. Journal of Bacteriology, 1991, 173(10):3228-3230; Eikmanns B J, Eggeling L, Sahm H. Molecular aspects of lysine, threonine, and isoleucine biosynthesis in Corynebacterium glutamicum.[J]. Antonie Van Leeuwenhoek, 1993, 64(2):145-163); and attenuating the coding gene glyA in the threonine utilization pathway and overexpressing the threonine export protein ThrE (Simic P, Willuhn J, Sahm H, et al. Identification of glyA (Encoding Serine Hydroxymethyltransferase) and Its Use Together with the Exporter ThrE To Increase 1-Threonine Accumulation by Corynebacterium glutamicum[J]. Applied and Environmental Microbiology, 2002, 68(7):3321-3327), etc. However, there are still few reports on the supply of precursors for threonine production.
The objective of the present invention is to provide a recombinant microorganism for producing threonine by modifying a promoter region of a gene encoding phosphoenolpyruvate carboxylase to improve the threonine-producing ability of a strain, and use of the recombinant microorganism.
Specifically, the present invention provides the following technical solutions: First, the present invention provides use of improved expression of the gene encoding phosphoenolpyruvate carboxylase (ppc) in increasing the threonine production of Corynebacterium bacteria or constructing threonine producing Corynebacterium bacteria, wherein the improved expression is achieved by replacing 20-30 bp upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase with a strong promoter.
The Corynebacterium bacteria described above are preferably Corynebacterium glutamicum.
The present invention finds that in Corynebacterium glutamicum, increasing the enzymatic activity of phosphoenolpyruvate carboxylase is beneficial to increasing the supply of oxaloacetate, a precursor of threonine synthesis, and further promoting the synthesis and accumulation of threonine. With regard to methods to increase the enzyme activity of phosphoenolpyruvate carboxylase, the present invention has conducted a large number of attempts and screenings, and unexpectedly found that replacing the specific region in the non-coding region upstream of the gene encoding phosphoenolpyruvate carboxylase with a strong promoter can significantly increase the expression quantity of phosphoenolpyruvate carboxylase. Compared to increasing the copy number of the gene, this modification method has higher stability. Moreover, compared to replacing the promoter of ppc with a stronger promoter, this modification is significantly better in improving the enzyme activity of phosphoenolpyruvate carboxylase.
Preferably, the enhanced expression is achieved by replacing 27 bp upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase with a strong promoter.
Further preferably, the strong promoter is Ptuf. The nucleotide sequence of the strong promoter Ptuf is as shown in SEQ ID NO. 4.
In order to enhance gene expression, a strong promoter is often used to replace the original promoter of the gene or directly inserted upstream of the start codon of the gene. When replacing the promoter, all the spacer sequence between the gene of interest and the upstream gene is usually replaced with a strong promoter, or the original promoter region of the gene of interest is replaced with a strong promoter. However, the present invention found that replacing the 27 bp DNA segment upstream of the start codon with a strong promoter (especially the strong promoter Ptuf) is significantly better in increasing the expression quantity of phosphoenolpyruvate carboxylase than replacing the promoter region of the gene encoding phosphoenolpyruvate carboxylase.
The 27 bp segment upstream of the start codon of the present invention means that: the first base upstream of the start codon is taken as the base at position 1 and extended upstream to the base at position 27 to obtain a DNA segment with a length of 27 bp. Taking the wild-type strain of Corynebacterium glutamicum ATCC13032 as an example, the sequence of the 27 bp segment upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase is as shown in SEQ ID NO.3.
The amino acid sequence of the phosphoenolpyruvate carboxylase of the present invention is shown in SEQ ID NO.1 or 2, or an amino acid sequence having at least 90% similarity to and having equivalent functions as the sequence shown in SEQ ID NO.1 or 2.
Preferably, the amino acid sequence of phosphoenolpyruvate carboxylase is as shown in SEQ ID NO. 1 or 2.
The sequence shown in SEQ ID NO.1 is the amino acid sequence of wild-type phosphoenolpyruvate carboxylase of Corynebacterium glutamicum. The sequence shown in SEQ ID NO.2 is a mutant protein (D299N) obtained by mutating the D at position 299 to N based on the wild-type phosphoenolpyruvate carboxylase of Corynebacterium glutamicum. On the basis of the above modification of the promoter region, combined with the mutation D299N of phosphoenolpyruvate carboxylase, the threonine production of the strain can be significantly improved. The amino acid sequence of phosphoenolpyruvate carboxylase is as shown in SEQ ID NO. 2.
Further, the present invention provides a recombinant microorganism, in which the 20-30 bp segment upstream of an start codon of the gene encoding phosphoenolpyruvate carboxylase is replaced with a strong promoter.
Preferably, a 27 bp segment upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase in the recombinant microorganism is replaced with a strong promoter.
Further preferably, the strong promoter is Ptuf.
The amino acid sequence of the phosphoenolpyruvate carboxylase described above is shown in SEQ ID NO.1 or 2, or an amino acid sequence having at least 90% similarity to and having equivalent functions as the sequence shown in SEQ ID NO.1 or 2.
Preferably, the amino acid sequence of phosphoenolpyruvate carboxylase is as shown in SEQ ID NO. 1 or 2. On the basis of the above modification of the promoter region, combined with the mutation D299N of phosphoenolpyruvate carboxylase, the threonine production of the strain can be significantly improved. Therefore, it is preferable that the amino acid sequence of the phosphoenolpyruvate carboxylase of the recombinant microorganism is as shown in SEQ ID NO.2.
The recombinant microorganism described above is preferably constructed by the following method: in the original strain, the 27 bp segment upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase of the original strain is replaced with a strong promoter Ptuf. Preferably, the method further comprises the step of mutating the gene encoding phosphoenolpyruvate carboxylase so that the phosphoenolpyruvate carboxylase obtains the D299N mutation.
Among them, the original strain is preferably a strain that can accumulate threonine.
Preferably, the enzyme activity of any one or more of the following enzymes (1) to (7) is enhanced and/or the feedback inhibition thereof is deregulated in the recombinant microorganism:
The above-mentioned aspartate kinase, homoserine dehydrogenase, aspartate semialdehyde dehydrogenase, aspartate aminotransferase, homoserine kinase, and threonine synthase have reference sequence numbers of WP_003855724.1, WP_003854900.1, WP_011013506.1, WP_011013497.1, WP_011014183.1, and WP_011014964.1 on NCBI, respectively, or amino acid sequences with at least 90% similarity to and equivalent functions as the above-mentioned reference sequences.
The threonine export protein derived from Escherichia coli has a reference sequence number of YP_026264.1 on NCBI, or an amino acid sequence with at least 90% similarity to and equivalent function as the above reference sequence.
Preferably, the microorganism is any of the following (1) to (6):
The enhancement of the activity of the above enzymes is achieved by any one selected from the following 1) to 6), or an optional combination thereof:
As a preferred scheme of the present invention, the recombinant microorganism is any of the following (1)-(6):
Preferably, the above-mentioned enhanced enzyme activity or enhanced expression is achieved by replacing the original promoter of the gene with a strong promoter, or by mutating the start codon of the gene so that the amino acid at position 1 of the encoded protein is mutated from valine to methionine.
The strong promoter is preferably the promoter Psod, PcspB or Ptuf. Among them, the nucleotide sequences of promoters Psod and PcspB are as shown in SEQ ID NOs. 5 and 6, respectively.
Preferably, the enhanced expression of the gene encoding aspartate kinase and the gene encoding threonine synthase is achieved by replacing their original promoter with promoter Psod and their start codon GTG was replaced by ATG.
The enhanced expression of the gene encoding aspartate semialdehyde dehydrogenase and the gene encoding aspartate aminotransferase is achieved by replacing their original promoters with the promoter Psod.
The enhanced expression of the gene encoding homoserine dehydrogenase and the gene encoding homoserine kinase is achieved by replacing their original promoters with the promoter PcspB.
The expression of the threonine export protein of Escherichia coli can be achieved by integrating the expression cassette of the gene encoding the threonine export protein of Escherichia coli into the chromosome of the microorganism. The preferred integration site is downstream of the cg2009 gene, and the promoter of the expression cassette is Psod.
The feedback-resistant aspartate kinase described above is preferably achieved by the T311I mutation. The feedback-resistant homoserine dehydrogenase is preferably achieved by the G378E mutation.
The microorganism used to construct the recombinant microorganism described above is preferably a Corynebacterium bacterium, more preferably Corynebacterium glutamicum. Corynebacterium glutamatum includes ATCC13032, ATCC13870, ATCC13869, ATCC21799, ATCC21831, ATCC14067, ATCC13287, etc. (see NCBI Corynebacterium glutamicum evolutionary tree https://www.ncbi.nlm.nih.gov/genome/469), more preferably Corynebacterium glutamatum ATCC 13032.
The present invention further provides a method for constructing the recombinant microorganism described above, comprising: the 27 bp segment upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase of the original strain is replaced with a strong promoter Ptuf.
Preferably, the method further comprises mutating the gene encoding phosphoenolpyruvate carboxylase so that the phosphoenolpyruvate carboxylase got the D299N mutation.
Further preferably, the method further comprises: enhancing the enzyme activity and/or deregulating the feedback inhibition of any one or more of the following enzymes (1) to (7):
The above-mentioned modification methods, including gene enhancement, are all modification methods known to those skilled in the art, see MAN, Zaiwei. Systemic pathway engineering modification of Corynebacterium crenatum to produce L-arginine with high yield [D]. Jiangnan University, 2016; CUI, Yi. Metabolic engineering modification of Corynebacterium glutamicum to produce L-leucine [D]. Tianjin University of Science and Technology; Xu Guodong. Construction of L-isoleucine producing strain and optimization of fermentation conditions. Tianjin University of Science and Technology, 2015.
The present invention provides one of the following uses of the recombinant microorganism described above:
The present invention further provides a method for producing threonine or a derivative thereof by fermentation, the method comprises the steps of cultivating the recombinant microorganism described above and obtaining threonine or the derivative thereof by isolating threonine or the derivative thereof from the culture.
Specifically, the above method comprises that: the recombinant microorganism is inoculated in a seed medium to obtain a seed liquid, the seed liquid is inoculated in a fermentation medium to obtain a fermentation liquid, and the fermentation liquid is separated and extracted to obtain threonine or a derivative thereof.
Preferably, the fermentation medium comprises the following components: corn steep liquor 45-55 mL/L, glucose 25-35 g/L, ammonium sulfate 3-5 g/L, MOPS 25-35 g/L, potassium dihydrogen phosphate 8-12 g/L, urea 15-25 g/L, biotin 8-12 mg/L, magnesium sulfate 5-7 g/L, ferrous sulfate 0.5-1.5 g/L, VB1·HCl 35-45 mg/L, calcium pantothenate 45-55 mg/L, nicotinamide 35-45 mg/L, manganese sulfate 0.5-1.5 g/L, zinc sulfate 15-25 mg/L, copper sulfate 15-25 mg/L, pH 7.0-7.2.
The beneficial effects of the present invention are as follows: the present invention significantly improved the ability of the strain to synthesize threonine by means of the specific optimization of the promoter of the gene encoding phosphoenolpyruvate carboxylase and the mutation of the encoding region of the gene, and the threonine production is increased by 25-40% compared to the strain without the above modification. The above modification method can be applied to the construction of threonine-producing strains and fermentative production of threonine, and has good application value.
The following examples are intended to illustrate the present invention but are not intended to limit the scope of the present invention.
The present invention focuses on investigating the impact of modification of the promoter region of phosphoenolpyruvate carboxylase on threonine production. It has been verified that replacing 20-30 bp, preferably 27 bp, upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase with a strong promoter can significantly increase the production of threonine.
The present invention further strengthens the threonine synthesis and transport pathways of the strain, mainly including expression enhancement or deregulating of aspartate kinase, homoserine dehydrogenase, aspartate semialdehyde dehydrogenase, aspartate aminotransferase, homoserine kinase, threonine synthase, and threonine export protein. The results of the shake flasks showed that the threonine-producing ability of all threonine-producing strains was improved after the 20-30 bp upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase was replaced with a strong promoter. At the same time, compared to the strain in which only the 20-30 bp upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase was replaced with a strong promoter, the strain in which the 20-30 bp upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase was replaced with a strong promoter and the expression of enzymes involved in the threonine synthesis and transport pathways was enhanced had more advantages in the production of threonine.
Expression enhancement during the modification process includes methods such as promoter replacement, change of ribosome binding sites, increase in copy number, and plasmid overexpression, and the above means are all well known to researchers in the art. The above means cannot be exhaustive through examples, and the specific embodiments only use enhancement by promoter as a representative for illustration.
A first technical solution of the present invention provides a method for producing threonine by a strain in which the 20-30 bp segment upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase is replaced with a strong promoter, and the expression of aspartate aminotransferase is enhanced and/or deregulated.
A second technical solution of the present invention provides a method for producing threonine by a strain in which the 20-30 bp segment upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase is replaced with a strong promoter, and the expression of at least one of aspartate aminotransferase, aspartate kinase, and aspartate semialdehyde dehydrogenase is enhanced and/or deregulated.
A third technical solution of the present invention provides a method for producing threonine by a strain in which the 20-30 bp segment upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase is replaced with a strong promoter, and the expression of at least one of aspartate aminotransferase, aspartate kinase, aspartate semialdehyde dehydrogenase, and homoserine dehydrogenase is enhanced and/or deregulated.
A fourth technical solution of the present invention provides a method for producing threonine by a strain in which the 20-30 bp segment upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase is replaced with a strong promoter, and the expression of at least one of aspartate aminotransferase, aspartate kinase, aspartate semialdehyde dehydrogenase, homoserine dehydrogenase, and homoserine kinase is enhanced and/or deregulated.
A fifth technical solution of the present invention provides a method for producing threonine by a strain in which the 20-30 bp segment upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase is replaced with a strong promoter, and the expression of at least one of aspartate aminotransferase, aspartate kinase, aspartate semialdehyde dehydrogenase, homoserine dehydrogenase, homoserine kinase, and threonine synthase is enhanced and/or deregulated.
A sixth technical solution of the present invention provides a method for producing threonine by a strain in which the 20-30 bp segment upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase is replaced with a strong promoter, and the expression of at least one of aspartate aminotransferase, aspartate kinase, aspartate semialdehyde dehydrogenase, homoserine dehydrogenase, homoserine kinase, threonine synthase, and threonine export protein is enhanced and/or deregulated.
The above-mentioned strain is a Corynebacterium bacterium, preferably Corynebacterium glutamicum, and most preferably Corynebacterium glutamicum ATCC 13032.
The detailed information of the enzymes and genes involved in the present invention are as follows:
1. Construction of the Plasmid pK18mobsacB-Psod-lysCg1a-T311I-Asd for Enhancing Expression of Aspartate Kinase-Aspartate Semialdehyde Dehydrogenase Operon
The upstream homologous arm up was obtained by PCR amplification with P21/P22 primer pair using ATCC13032 genome as template, the promoter segment Psod was obtained by PCR amplification with P23/P24 primer pair, lysCg1a-T311I was obtained by PCR amplification with P25/P26 primer pair, and the downstream homologous arm dn was obtained by PCR amplification with P27/P28 primer pair. The up-Psod segment was obtained by fusion PCR with P21/P24 primer pair using up and Psod as templates. The full-length segment up-Psod-lysCg1a-T311I-dn was obtained by fusion PCR with P21/P28 primer pair using up-Psod, lysCg1a-T311I and dn as templates. pK18mobsacB was digested with BamHI/HindIII. Enzyme-digested pK18mobsacB and up-Psod-lysCg1a-T311I-dn and were assembled using a seamless cloning kit and transformed into Trans1 T1 competent cells to obtain the recombinant plasmid pK18mobsacB-Psod-lysCg1a-T311I-asd.
2. Construction of the Plasmid pK18mobsacB-Psod-aspB for Enhancing Expression of Aspartate Aminotransferase
The plasmid construction method was referred to above 1, and the primers used were P103, P104, P105, P106, P107 and P108.
3. Construction of Plasmid pK18mobsacB-PcspB-HomG378E-thrB for Enhancing Expression of Homoserine Dehydrogenase-Homoserine Kinase Operon
The plasmid construction method was referred to above 1, and the primers used were P29, P30, P31, P32, P33, P34, P35, and P36.
4. Construction of the Plasmid pK18mobsacB-Psod-thrCg1a for Enhancing Expression of Threonine Synthase
The plasmid construction method was referred to above 1, and the primers used were P37, P38, P39, P40, P41 and P42.
5. Construction of the Plasmid pK18mobsacB-Psod-rhtC for Enhancing Expression of Threonine Export Protein
The plasmid construction method was referred to above 1, and the primers used were P157, P158, P159, P160, P161, P162, P163 and P164.
6. Construction of the Plasmid pK18mobsacB-Ptuf-PpcD299N for Enhancing Expression of Phosphoenolpyruvate Carboxylase
The upstream homologous arm up was obtained by PCR amplification with P53/P54 primer pair using ATCC13032 genome as template, the promoter segment Ptuf was obtained by PCR amplification with P55/P56 primer pair, ppcD299N was obtained by PCR amplification with P57/P58 primer pair, and the downstream homologous arm dn was obtained by PCR amplification with P59/P60 primer pair. The segment up-Ptuf was obtained by fusion PCR with P53/P56 primer pair using up and Ptuf as templates. The full length segment up-Ptuf-ppcD299N_dn was obtained by fusion PCR with P53/P60 primer pair using up-Ptuf, ppcD299N and dn as templates. pK18mobsacB was digested with BamHI/HindIII. Enzyme-digested pK18mobsacB and up-Ptuf-ppcD299N-dn were assembled using a seamless cloning kit and transformed into Trans1 T1 competent cells to obtain the recombinant plasmid pK18mobsacB-Ptuf-ppcD299N.
The primers used in the above plasmid construction process are shown in Table 1.
1. Construction of a Strain with Enhanced Expression of Aspartate Aminotransferase
ATCC13032 competent cells were prepared according to the classic method of Corynebacterium glutamicum (C. glutamicum Handbook, Chapter 23). The competent cells were transformed with the recombinant plasmid pK18mobsacB-Psod-aspB by electroporation, and transformants were screened on a selection medium containing 15 mg/L kanamycin, and the gene of interest was inserted into the chromosome due to homology. The screened transformants were cultured overnight in a normal liquid brain-heart infusion medium at 30° C. under shaken at 220 rpm on a rotary shaker. During this culture process, the transformants underwent a second recombination, removing the vector sequence from the genome through gene exchange. The culture was diluted in a serial gradient (10−2 to 10−4), and the dilutions were spread on a normal solid brain-heart infusion medium containing 10% sucrose and subjected to static culture at 33° C. for 48 h. Strains grown on sucrose medium did not carry the inserted vector sequences in their genome. The fragment of interest was amplified by PCR and analyzed by nucleotide sequencing to obtain the mutant strain of interest named SMCT061. Compared to strain ATCC13032, the promoter of the aspB gene in this strain was replaced with the Psod promoter.
2. Construction of a Strain with Enhanced Expression of Aspartate Kinase-Aspartate Semialdehyde Dehydrogenase Operon
The strain construction method was referred to the above 1. SMCT061 was used as the original strain, and the pK18mobsacB-Psod-lysCg1a-T311I-asd plasmid was introduced into SMCT061 to perform modification for enhancing aspartate kinase-aspartate semialdehyde dehydrogenase operon. The obtained strain was named SMCT062. Compared to strain SMCT061, the lysC gene of this strain was mutated, resulting in its start codon to mutate from GTG to ATG, and the position 311 of the encoded amino acid sequence to mutate from threonine to isoleucine, and the promoter of the lysC-asd operon was replaced with the Psod promoter.
3. Construction of a Strain with Enhanced Expression of Homoserine Dehydrogenase-Homoserine Kinase
The strain construction method was referred to the above 1. SMCT062 was used as the original strain, and the pK18mobsacB-PcspB-homG378E-thrB plasmid was introduced into SMCT062 to perform modification for enhancing the expression of homoserine dehydrogenase-homoserine kinase. The obtained modified strain was named SMCT063. Compared to the original strain SMCT062, the hom gene of this strain was mutated, resulting in the G378E mutation in its encoded protein, and the promoter of the hom-thrB operon was replaced with PcspB promoter.
4. Construction of a Strain with Enhanced Expression of Threonine Synthase
The strain construction method was referred to the above 1. SMCT063 was used as the original strain, and the pK18mobsacB-Psod-thrCg1a plasmid was introduced into SMCT063 to perform modification for enhancing the expression of threonine synthase. The obtained modified strain was named SMCT064. Compared to the strain SMCT063, the start codon of the thrC gene of this strain was mutated to ATG, and the promoter of the thrC gene was replaced with Psod.
5. Construction of a Strain with Enhanced Expression of Threonine Export Protein
The strain construction method was referred to the above 1. SMCT064 was used as the original strain, and the pK18mobsacB-Psod-rhtC plasmid was introduced into SMCT064 to perform modification for enhancing the expression of threonine export protein. The obtained modified strain was named SMCT065. Compared to SMCT064, the threonine export protein gene rhtC from Escherichia coli was inserted downstream of the cg2009 gene in this strain.
6. Construction of a Strain with Enhanced Expression of Phosphoenolpyruvate Carboxylase
The strain construction method was referred to the above 1. SMCT061, SMCT062, SMCT063, SMCT064, and SMCT065 were used as original strains, and the pK18mobsacB-Ptuf-ppcD299N plasmid was introduced into the above original strains, respectively, to perform modification for enhancing the expression of phosphoenolpyruvate carboxylase. The obtained modified strains were named SMCT066, SMCT067, SMCT068, SMCT079, and SMCT070, respectively. Compared to their corresponding original strains, the mutation of the gene ppc encoding phosphoenolpyruvate carboxylase in these modified strains caused the D299N mutation in the proteins encoded, and the 27 bp segment upstream of the start codon of the ppc gene was replaced with Ptuf promoter.
The genotypes of the above-mentioned strains obtained by genetic modification are shown in Table 2.
Each of the Modified Strains Constructed in Example 2 was Validated by Shake Flask fermentation as follows:
Seed activation medium: BHI 3.7%, agar 2%, pH 7.
Seed medium: Peptone 5/L, yeast extract 5 g/L, sodium chloride 10 g/L, ammonium sulfate 16 g/L, urea 8 g/L, potassium dihydrogen phosphate 10.4 g/L, dipotassium hydrogen phosphate 21.4 g/L, biotin 5 mg/L, magnesium sulfate 3 g/L. Glucose 50 g/L, pH 7.2.
Fermentation medium: corn steep liquor 50 mL/L, glucose 30 g/L, ammonium sulfate 4 g/L, MOPS 30 g/L, potassium dihydrogen phosphate 10 g/L, urea 20 g/L, biotin 10 mg/L, magnesium sulfate 6 g/L, ferrous sulfate 1 g/L, VB1·HCl 40 mg/L, calcium pantothenate 50 mg/L, nicotinamide 40 mg/L, manganese sulfate 1 g/L, zinc sulfate 20 mg/L, copper sulfate 20 mg/L, pH 7.2.
2. Production of L-Threonine by Shake Flask Fermentation with Engineered Strain
The results of shake flask fermentation for threonine are shown in Table 3.
The results showed that by optimizing the promoter of the gene encoding phosphoenolpyruvate carboxylase and engineering the D299N mutation on phosphoenolpyruvate carboxylase in the threonine-producing strains SMCT061, SMCT062, SMCT063, SMCT064, and SMCT065, the threonine production was further increased. The threonine production of strains SMCT066, SMCT067, SMCT068, SMCT069, and SMCT070 was increased by 25%, 33%, 35%, 38%, and 40%, respectively, indicating that by replacing the 20-30 bp segment upstream of the start codon of the gene encoding phosphoenolpyruvate carboxylase with a strong promoter and engineering the D299N mutation on phosphoenolpyruvate carboxylase, the supply of oxaloacetate, a precursor of threonine synthesis, could be increased, thereby promoting the synthesis of threonine. In addition, the threonine production was further increased by combining the modification of the above-mentioned phosphoenolpyruvate carboxylase with the enhanced expression of different enzymes in the threonine synthesis pathway and threonine export proteins, indicating that the combination of the above-mentioned modifications was more conducive to improving the threonine-producing ability of the strain.
Although the present invention has been described in detail above with general descriptions and specific embodiments, it is obvious to those skilled in the art that some modifications or improvements may be made based on the present invention. Therefore, these modifications or improvements made without departing from the spirit of the present invention belong to the scope of protection claimed by the present invention.
Corynebacterium glutamicum PPC wt
Corynebacterium glutamicum PPC D299N
| Number | Date | Country | Kind |
|---|---|---|---|
| 202210107366.3 | Jan 2022 | CN | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/CN2022/143106 | 12/29/2022 | WO |
